From: New insights into the regulation of METTL3 and its role in tumors
Cell or Tissue | Source | Noncoding RNA | Effects | In vitro/vivo | Animal experiments | Reference |
---|---|---|---|---|---|---|
Breast cancer | SUM-1315, MCF-7 | miR-483-3p | Inhibition | In vitro | Not involved | [32] |
MCF-7 | Let-7 g | Inhibition | In vitro | Not involved | [33] | |
MDA-MB-231, BT-549 | miR-34c-3p | Inhibition | In vitro | Not involved | [34] | |
Melanoma | SKMEL, HT-144 | miR-302a-3p | Inhibition | In vitro | Not involved | [35] |
Gastric cancer | AGS, MGC-803 | miR-193b-5p | Inhibition | In vitro | Not involved | [36] |
HCG-27, MGC-803 | miR-4429 | Inhibition | In vitro | Not involved | [37] | |
NCI-N87, SNU-16 | miR-1269b | Inhibition | In vitro | Not involved | [38] | |
SCG-7901, BGC-823 | miR-338-5p | Inhibition | In vitro | Not involved | [39] | |
NSCLC | A549, NCI-H460 | miR-33a | Inhibition | In vitro | Not involved | [40] |
A549, H1299 | miR-600 | Inhibition | In vitro | Not involved | [41] | |
A549-S, A549-R | miR-4443 | Inhibition | Both | Xenograft tumor model in nude mice | [42] | |
A549, H1650 | miR-590-5p | Inhibition | In vitro | Not involved | [43] | |
H1299/DDP, A549/DDP | miR-524-5p | Inhibition | In vitro | Not involved | [30] | |
Hepatocellular carcinoma | HepG2, HuH-6 | miR-186 | Inhibition | Both | Xenograft tumor model in mice | [44] |
Hep3B | miR24-2 | Promotion | In vitro | Not involved | [45] | |
Hep3B | miR-1301-3p | Inhibition | In vitro | Not involved | [46] | |
Nasopharyngeal Carcinoma | KY-SE150, Eca-9706 | miR-186-5p | Inhibition | In vitro | Not involved | [47] |
M1 macrophages | LN‐229 | miR-302a | Inhibition | In vitro | Not involved | [29] |
Human Cartilage Tissues | Osteoarthritis Samples | miR-373 | Inhibition | In vitro | Not involved | [48] |
HRVEC | tRF-1001 | Inhibition | Both | OIR mouse model | [49] | |
AML | Bone marrow samples of AML patients Molm13, HL-60 | miR-493-5p | Inhibition | In vitro | Not involved | [32] |